Crossfund Sicav-Cross.Healthcare Fd.A/ LU1334634299 /
NAV10/30/2024 | Chg.-1.3500 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
165.3400USD | -0.81% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | 0.73 | 0.35 | 0.27 | 4.65 | -0.99 | 2.47 | 3.15 | 1.85 | -4.61 | 3.90 | -4.19 | 5.94 | +13.73% |
2022 | -7.83 | -1.45 | 4.13 | -5.42 | -0.08 | -2.09 | 2.26 | -5.73 | -2.78 | 8.33 | 2.54 | 0.01 | -8.88% |
2023 | -2.01 | -3.06 | 1.76 | 3.74 | -3.93 | 3.55 | -0.14 | -1.13 | -2.87 | -5.81 | 4.36 | 6.08 | -0.24% |
2024 | 3.10 | 2.52 | 2.60 | -4.63 | 2.31 | 2.63 | 1.36 | 4.54 | -3.56 | -4.02 | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 10.25% | 10.10% | 10.51% | 12.64% | -% |
Sharpe ratio | 0.47 | 0.30 | 1.50 | -0.31 | - |
Best month | +6.08% | +4.54% | +6.08% | +8.33% | - |
Worst month | -4.63% | -4.63% | -5.81% | -7.83% | - |
Maximum loss | -7.43% | -7.43% | -7.43% | -19.23% | - |
Outperformance | - | - | - | - | - |
All quotes in USD
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Crossfund Sicav-Cross.Healthcare... | reinvestment | 131.3400 | +13.82% | -12.47% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 139.4500 | +16.67% | -8.59% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 165.3400 | +18.85% | -2.38% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 128.1600 | +13.41% | -13.46% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 160.5200 | +18.36% | -3.55% | |
CROSSFUND SICAV - Crossinvest He... | reinvestment | 135.9200 | +16.20% | -9.68% |
Performance
YTD | +6.51% | ||
---|---|---|---|
6 Months | +2.99% | ||
1 Year | +18.85% | ||
3 Years | -2.38% | ||
5 Years | - | ||
10 Years | - | ||
Since start | +10.40% | ||
Year | |||
2023 | -0.24% | ||
2022 | -8.88% | ||
2021 | +13.73% |